These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 15073809)

  • 21. Trends in antimalarial prescriptions in Australia 2002 to 2005.
    Leggat PA
    J Travel Med; 2008; 15(5):302-6. PubMed ID: 19006502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Examining the adequacy of quantities available for subsidized antidepressant prescriptions in Australia.
    McManus P; Mant A; Birkett D; Hemming M; Lindner J
    Pharmacoepidemiol Drug Saf; 1999 May; 8(3):191-5. PubMed ID: 15073928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in use of disease-modifying anti-rheumatic drugs in Australia over the period 1992-2004.
    Chan V; Tett SE
    Pharmacoepidemiol Drug Saf; 2006 Jul; 15(7):462-8. PubMed ID: 16700080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What happened to the prescribing of other COX-2 inhibitors, paracetamol and non-steroidal anti-inflammatory drugs when rofecoxib was withdrawn in Australia?
    Barozzi N; Tett SE
    Pharmacoepidemiol Drug Saf; 2007 Nov; 16(11):1184-91. PubMed ID: 17636557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of improved air quality on mortality risks in Erfurt, Germany.
    Peters A; Breitner S; Cyrys J; Stölzel M; Pitz M; Wölke G; Heinrich J; Kreyling W; Küchenhoff H; Wichmann HE
    Res Rep Health Eff Inst; 2009 Feb; (137):5-77; discussion 79-90. PubMed ID: 19554968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Free trade in pharmaceuticals.
    Outterson MK
    Med J Aust; 2004 Sep; 181(5):260-1. PubMed ID: 15347274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of a national quality use of medicines service in Australia: an evolving model.
    Beilby J; Wutzke SE; Bowman J; Mackson JM; Weekes LM
    J Eval Clin Pract; 2006 Apr; 12(2):202-17. PubMed ID: 16579830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Withdrawal of COX-2 selective inhibitors rofecoxib and valdecoxib: impact on NSAID and gastroprotective drug prescribing and utilization.
    Sun SX; Lee KY; Bertram CT; Goldstein JL
    Curr Med Res Opin; 2007 Aug; 23(8):1859-66. PubMed ID: 17605893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Medicare database review found that physician preferences increasingly outweighed patient characteristics as determinants of first-time prescriptions for COX-2 inhibitors.
    Schneeweiss S; Glynn RJ; Avorn J; Solomon DH
    J Clin Epidemiol; 2005 Jan; 58(1):98-102. PubMed ID: 15649677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Moral hazard and prescription medicine use in Australia--the patient perspective.
    Doran E; Robertson J; Henry D
    Soc Sci Med; 2005 Apr; 60(7):1437-43. PubMed ID: 15652677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health care financing and public responses: use of private insurance in Western Australia during 1980-2001.
    Moorin R; Brameld KJ; Holman CD
    Aust Health Rev; 2006 Feb; 30(1):73-82. PubMed ID: 16448380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improving medication safety: influence of a patient-specific prescriber feedback program on rate of medication reviews performed by Australian general medical practitioners.
    Roughead E; Pratt N; Peck R; Gilbert A
    Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):797-803. PubMed ID: 17476702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmaceutical insurance and the demand for prescription pharmaceuticals in Västerbotten, Sweden.
    Rudholm N
    Scand J Public Health; 2005; 33(1):50-6. PubMed ID: 15764241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of a fluoroquinolone restriction policy in an elderly population.
    Mamdani M; McNeely D; Evans G; Hux J; Oh P; Forde N; Conly J
    Am J Med; 2007 Oct; 120(10):893-900. PubMed ID: 17904461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of a Medicaid copayment policy on prescription drug and health services utilization in a fee-for-service Medicaid population.
    Hartung DM; Carlson MJ; Kraemer DF; Haxby DG; Ketchum KL; Greenlick MR
    Med Care; 2008 Jun; 46(6):565-72. PubMed ID: 18520310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alprazolam prescribing in Tasmania: a two-fold intervention designed to reduce inappropriate prescribing and concomitant opiate prescription.
    Hooper S; Bruno R; Sharpe M; Tahmindjis A
    Australas Psychiatry; 2009 Aug; 17(4):300-5. PubMed ID: 19585293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utilization, price, and spending trends for antidepressants in the US Medicaid Program.
    Chen Y; Kelton CM; Jing Y; Guo JJ; Li X; Patel NC
    Res Social Adm Pharm; 2008 Sep; 4(3):244-57. PubMed ID: 18794035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of mailed warning to prescribers on the co-prescription of tramadol and antidepressants.
    Shatin D; Gardner JS; Stergachis A; Blough D; Graham D
    Pharmacoepidemiol Drug Saf; 2005 Mar; 14(3):149-54. PubMed ID: 15386714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Introducing co-payment for consultant specialist services.
    Vardy DA; Freud T; Shvartzman P; Sherf M; Spilberg O; Goldfarb D; Mor-Yosef S
    Isr Med Assoc J; 2006 Aug; 8(8):558-62. PubMed ID: 16958247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.